​
​

Replimune Group (REPL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Replimune Group Revenue Highlights

00

Replimune Group Revenue by Period

Replimune Group Revenue by Year

DateRevenueChange
2024-03-31-100.00%
2023-03-31-100.00%
2022-03-31-100.00%
2021-03-31-100.00%
2020-03-31-100.00%
2019-03-31-100.00%
2018-03-31-100.00%
2017-03-31--

Replimune Group generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Replimune Group Revenue by Quarter

DateRevenueChange
2024-06-30--100.00%
2024-03-31$4.04M100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Replimune Group generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Replimune Group Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
UTHRUnited Therapeutics$2.33B$748.90M
ASNDAscendis Pharma$266.72M$95.89M
PTGXProtagonist Therapeutics$60.00M$4.67M
MRUSMerus$43.95M$11.77M
NAMSNewAmsterdam Pharma Company$14.09M$2.13M
KRONKronos Bio$6.29M$2.37M
CRNXCrinetics Pharmaceuticals$4.01M-
PRTCPureTech Health$3.33M$178.57K
LYRALyra Therapeutics$1.56M$195.00K
KROSKeros Therapeutics$151.00K$37.00K
NUVLNuvalent--
GOSSGossamer Bio-$9.48M
AVTEAerovate Therapeutics--
CERECerevel Therapeutics--
REPLReplimune Group--
KURAKura Oncology--
SNDXSyndax Pharmaceuticals-$12.50M
VTYXVentyx Biosciences--
MLYSMineralys Therapeutics--
NVCTNuvectis Pharma--

REPL Revenue FAQ

What is Replimune Group’s yearly revenue?

Replimune Group's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. REPL's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Replimune Group’s quarterly revenue?

Replimune Group's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $4.04M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). REPL's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Replimune Group’s revenue growth rate?

Replimune Group's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.